Makkonen N, Hirvonen M R, Savolainen K, Lapinjoki S, Mönkkönen J
Department of Pharmaceutics, University of Kuopio, Finland.
Inflamm Res. 1995 Dec;44(12):523-8. doi: 10.1007/BF01757356.
The aim of this study was to evaluate the effect of gallium nitrate, gallium-nitrilotriacetate (NTA) complex, and liposomal gallium-NTA on IL-6, TNF alpha, and nitric oxide (NO) release from activated macrophages. In addition, the expression of the inducible nitric oxide synthase (iNOS) was determined. Gallium inhibited dose-dependently the secretion of IL-6, TNF alpha, and NO from the LPS-induced macrophage-like RAW 264 cells. Encapsulation of gallium in negatively charged DSPG-liposomes increased its potency 10-50 times and 7-11 times compared to free gallium nitrate and gallium-NTA, respectively. Neither non-loaded liposomes nor NTA alone inhibited cytokine or NO secretion, demonstrating that the observed effects originated from gallium. Liposomal gallium-NTA inhibited the expression of iNOS by the macrophages, while other formulations of gallium had no effect. Thus, gallium, when delivered properly, suppresses macrophage functions by inhibiting the release of inflammatory mediators from the cells.
本研究的目的是评估硝酸镓、镓-次氮基三乙酸(NTA)络合物和脂质体镓-NTA对活化巨噬细胞释放白细胞介素-6(IL-6)、肿瘤坏死因子α(TNFα)和一氧化氮(NO)的影响。此外,还测定了诱导型一氧化氮合酶(iNOS)的表达。镓剂量依赖性地抑制脂多糖诱导的巨噬细胞样RAW 264细胞分泌IL-6、TNFα和NO。与游离硝酸镓和镓-NTA相比,将镓包裹在带负电荷的二硬脂酰磷脂酰甘油(DSPG)脂质体中可使其效力分别提高10 - 50倍和7 - 11倍。未负载的脂质体和单独的NTA均未抑制细胞因子或NO的分泌,表明观察到的效应源自镓。脂质体镓-NTA抑制巨噬细胞中iNOS的表达,而其他镓制剂则无此作用。因此,当镓以适当方式递送时,可通过抑制细胞释放炎性介质来抑制巨噬细胞功能。